NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 30,482 shares, an increase of 1,265.7% from the April 15th total of 2,232 shares. Based on an average daily trading volume, of 56,523 shares, the days-to-cover ratio is currently 0.5 days.
NRx Pharmaceuticals Stock Performance
Shares of NRx Pharmaceuticals stock opened at $0.01 on Tuesday. The business has a fifty day simple moving average of $0.02 and a 200-day simple moving average of $0.05. NRx Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.18.
About NRx Pharmaceuticals
NRx Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for neuropsychiatric and neurodegenerative disorders. The company’s research pipeline includes small‐molecule candidates designed to address underlying pathophysiological mechanisms implicated in conditions such as Rett syndrome, Alzheimer’s disease and Long COVID. Leveraging a proprietary formulation and delivery approach, NRx seeks to advance compounds that have demonstrated safety in prior studies toward new indications with significant unmet medical need.
Among its lead programs, NRx is developing NP-120 (sarizotan) for the treatment of Rett syndrome, a rare genetic disorder that impacts brain development in young girls.
Further Reading
- Five stocks we like better than NRx Pharmaceuticals
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
Receive News & Ratings for NRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
